References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2014 update [webpage on the Internet]Global Initiative for Chronic Obstructive Lung Disease, Inc2014 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed July 11, 2014
- WedzichaJADonaldsonGCExacerbations of chronic obstructive pulmonary diseaseRespir Care200348121204121314651761
- JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185Suppl B25311759018
- DeshpandePRRajanSSudeepthiBLAbdul NazirCPPatient-reported outcomes: A new era in clinical researchPerspect Clin Res20112413714422145124
- ByromBTipladyBePRO: Electronic Solutions for Patient-Reported DataSurreyGower2010
- IrelandAMWiklundIHsiehRDalePO’RourkeEAn electronic diary is shown to be more reliable than a paper diary: results from a randomized crossover study in patients with persistent asthmaJ Asthma201249995296023033885
- BjornerJBRoseMGandekBStoneAAJunghaenelDUWareJEMethod of administration of PROMIS scales did not significantly impact score level, reliability, or validityJ Clin Epidemiol201467110811324262772
- StoneAAShiffmanSSchwartzJEBroderickJEHuffordMRPatient non-compliance with paper diariesBMJ200232473471193119412016186
- StullDELeidyNKParasuramanBChassanyOOptimal recall periods for patient-reported outcomes: challenges and potential solutionsCurr Med Res Opin200925492994219257798
- JonesPMiravitllesMvan der MolenTKulichKBeyond FEV1 in COPD: a review of patient-reported outcomes and their measurementInt J Chron Obstruct Pulmon Dis2012769770923093901
- US Department of Health and Human Services Food and Drug AdministrationGuidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims2009Silver Spring, MDFDA Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdfAccessed February 18, 2014
- BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
- VogelmeierCFBatemanEDPallanteJEfficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyLancet Respir Med201311516024321804
- DahlRChapmanKRRudolfMSafety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN studyRespir Med2013107101558156723867808
- WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
- BaldwinMJKulichKTipladyBGwaltneyCClineJEvaluation of an electronic daily diary for measuring morning symptoms in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187A2517
- BaldwinMKulichKTipladyBGwaltneyCClineJSymptoms and impact of COPD assessed by a handheld electronic diaryPoster presented at: 2013 Meeting of the European Respiratory SocietySeptember 7–11, 2013Barcelona, Spain Poster P4903
- MahlerDAFaryniarzKTomlinsonDImpact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary diseaseChest199210223954011643921
- TsiligianniIKocksJTzanakisNSiafakasNvan der MolenTFactors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlationsPrim Care Respir J201120325726821472192
- MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest19848567517586723384
- O’ConnorBPSPSS and SAS programs for determining the number of components using parallel analysis and velicer’s MAP testBehav Res Methods Instrum Comput200032339640211029811
- ShroutPEFleissJLIntraclass correlations: uses in assessing rater reliabilityPsychol Bull197986242042818839484
- HillemanDEDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPDChest200011851278128511083675
- JonesPWDonohueJFNedelmanJPascoeSPinaultGLassenCCorrelating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysisRespir Res20111216122206353
- KernsKDeckerSNMultifactorial assessment of reading disability: identifying the best predictorsPercept Mot Skills19856037477534022726
- FraenkelLFalzerPFriedTMeasuring pain impact versus pain severity using a numeric rating scaleJ Gen Intern Med201227555556022081365
- MorrenMvan DulmenSOuwerkerkJBensingJCompliance with momentary pain measurement using electronic diaries: a systematic reviewEur J Pain200913435436518603458
- MahlerDAWardJWatermanLAMcCuskerCZuwallackRBairdJCPatient-reported dyspnea in COPD reliability and association with stage of diseaseChest200913661473147919696126
- CohenJStatistical Power Analysis for the Behavioral SciencesNew York, NYAcademic Press1977